These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18980800)

  • 21. MUTYH-associated polyposis (MAP).
    Nielsen M; Morreau H; Vasen HF; Hes FJ
    Crit Rev Oncol Hematol; 2011 Jul; 79(1):1-16. PubMed ID: 20663686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implication of adenomatous polyposis coli and MUTYH mutations in familial colorectal polyposis.
    De Rosa M; Galatola M; Borriello S; Duraturo F; Masone S; Izzo P
    Dis Colon Rectum; 2009 Feb; 52(2):268-74. PubMed ID: 19279422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic c.34G>T KRAS mutation: a new prescreening test for MUTYH-associated polyposis?
    Aimé A; Coulet F; Lefevre JH; Colas C; Cervera P; Flejou JF; Lascols O; Soubrier F; Parc Y
    Cancer Genet; 2015; 208(7-8):390-5. PubMed ID: 26056087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered expression of MUTYH and an increase in 8-hydroxydeoxyguanosine are early events in ulcerative colitis-associated carcinogenesis.
    Gushima M; Hirahashi M; Matsumoto T; Fujita K; Fujisawa R; Mizumoto K; Nakabeppu Y; Iida M; Yao T; Tsuneyoshi M
    J Pathol; 2009 Sep; 219(1):77-86. PubMed ID: 19479711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype.
    Aretz S; Uhlhaas S; Goergens H; Siberg K; Vogel M; Pagenstecher C; Mangold E; Caspari R; Propping P; Friedl W
    Int J Cancer; 2006 Aug; 119(4):807-14. PubMed ID: 16557584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and characteristics of MUTYH-associated polyposis in patients with multiple adenomatous and serrated polyps.
    Guarinos C; Juárez M; Egoavil C; Rodríguez-Soler M; Pérez-Carbonell L; Salas R; Cubiella J; Rodríguez-Moranta F; de-Castro L; Bujanda L; Serradesanferm A; Nicolás-Pérez D; Herráiz M; Fernández-Bañares F; Herreros-de-Tejada A; Aguirre E; Balmaña J; Rincón ML; Pizarro A; Polo-Ortiz F; Castillejo A; Alenda C; Payá A; Soto JL; Jover R
    Clin Cancer Res; 2014 Mar; 20(5):1158-68. PubMed ID: 24470512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endometrial cancer may be part of the MUTYH-associated polyposis cancer spectrum.
    Villy MC; Masliah-Planchon J; Buecher B; Beaulaton C; Vincent-Salomon A; Stoppa-Lyonnet D; Colas C
    Eur J Med Genet; 2022 Jan; 65(1):104385. PubMed ID: 34775073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of MUTYH-associated neoplasia in Australia.
    Worthley DL; Suthers G; Lipton L
    Intern Med J; 2008 Aug; 38(8):644-50. PubMed ID: 18298557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of germline MUTYH mutations among Lynch-like syndrome patients.
    Castillejo A; Vargas G; Castillejo MI; Navarro M; Barberá VM; González S; Hernández-Illán E; Brunet J; Ramón y Cajal T; Balmaña J; Oltra S; Iglesias S; Velasco A; Solanes A; Campos O; Sánchez Heras AB; Gallego J; Carrasco E; González Juan D; Segura A; Chirivella I; Juan MJ; Tena I; Lázaro C; Blanco I; Pineda M; Capellá G; Soto JL
    Eur J Cancer; 2014 Sep; 50(13):2241-50. PubMed ID: 24953332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of the colorectal cancer risk associated with MUTYH mutation.
    Lubbe SJ; Di Bernardo MC; Chandler IP; Houlston RS
    J Clin Oncol; 2009 Aug; 27(24):3975-80. PubMed ID: 19620482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients.
    Croitoru ME; Cleary SP; Berk T; Di Nicola N; Kopolovic I; Bapat B; Gallinger S
    J Surg Oncol; 2007 May; 95(6):499-506. PubMed ID: 17219385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duodenal carcinoma in MUTYH-associated polyposis.
    Nielsen M; Poley JW; Verhoef S; van Puijenbroek M; Weiss MM; Burger GT; Dommering CJ; Vasen HF; Kuipers EJ; Wagner A; Morreau H; Hes FJ
    J Clin Pathol; 2006 Nov; 59(11):1212-5. PubMed ID: 16943222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Base excision repair deficiency signatures implicate germline and somatic
    Thibodeau ML; Zhao EY; Reisle C; Ch'ng C; Wong HL; Shen Y; Jones MR; Lim HJ; Young S; Cremin C; Pleasance E; Zhang W; Holt R; Eirew P; Karasinska J; Kalloger SE; Taylor G; Majounie E; Bonakdar M; Zong Z; Bleile D; Chiu R; Birol I; Gelmon K; Lohrisch C; Mungall KL; Mungall AJ; Moore R; Ma YP; Fok A; Yip S; Karsan A; Huntsman D; Schaeffer DF; Laskin J; Marra MA; Renouf DJ; Jones SJM; Schrader KA
    Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30833417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of current testing practices for biallelic MUTYH mutations in MUTYH-associated polyposis.
    Landon M; Ceulemans S; Saraiya DS; Strike B; Arnell C; Burbidge LA; Moyes K; Theisen A; Fernandes PH; Ji JQ; Abbott B; Kaldate RR; Roa B
    Clin Genet; 2015 Apr; 87(4):368-72. PubMed ID: 24620956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA glycosylase encoded by MUTYH functions as a molecular switch for programmed cell death under oxidative stress to suppress tumorigenesis.
    Oka S; Nakabeppu Y
    Cancer Sci; 2011 Apr; 102(4):677-82. PubMed ID: 21235684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of MUTYH function in human cells leads to accumulation of oxidative damage and genetic instability.
    Ruggieri V; Pin E; Russo MT; Barone F; Degan P; Sanchez M; Quaia M; Minoprio A; Turco E; Mazzei F; Viel A; Bignami M
    Oncogene; 2013 Sep; 32(38):4500-8. PubMed ID: 23108399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer.
    Viel A; Bruselles A; Meccia E; Fornasarig M; Quaia M; Canzonieri V; Policicchio E; Urso ED; Agostini M; Genuardi M; Lucci-Cordisco E; Venesio T; Martayan A; Diodoro MG; Sanchez-Mete L; Stigliano V; Mazzei F; Grasso F; Giuliani A; Baiocchi M; Maestro R; Giannini G; Tartaglia M; Alexandrov LB; Bignami M
    EBioMedicine; 2017 Jun; 20():39-49. PubMed ID: 28551381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rectum-sparing surgery may be appropriate for biallelic MutYH-associated polyposis.
    Nascimbeni R; Pucciarelli S; Di Lorenzo D; Urso E; Casella C; Agostini M; Nitti D; Salerni B
    Dis Colon Rectum; 2010 Dec; 53(12):1670-5. PubMed ID: 21178863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis.
    Russo MT; De Luca G; Casorelli I; Degan P; Molatore S; Barone F; Mazzei F; Pannellini T; Musiani P; Bignami M
    Cancer Res; 2009 May; 69(10):4372-9. PubMed ID: 19435918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia.
    Hayes MP; Wang H; Espinal-Witter R; Douglas W; Solomon GJ; Baker SJ; Ellenson LH
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5932-5. PubMed ID: 17062663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.